Patents Assigned to IQUITY, INC.
  • Long non-coding RNA gene expression signatures in disease monitoring and treatment
    Patent number: 10982259
    Abstract: Differential expression of long non-coding RNAs (lncRNAs) and enhancer RNAs (eRNAs) are used to monitor diseases and determine therapeutic efficacy in, for example, neurological diseases, inflammatory diseases, rheumatic diseases, and autoimmune diseases. Machine learning systems are used to identify lncRNAs or eRNAs having differential expression correlated with responsiveness to various therapies.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: April 20, 2021
    Assignee: IQUITY, INC.
    Inventor: Charles Floyd Spurlock, III